Peter C Farrell insider trades

Open-market stock purchases and sales by Peter C Farrell, Director at Resmed Inc, from SEC Form 4 filings since Jan 4, 2010.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -21%.

Recent trades

DateStockTradeValue
Sep 2, 2026RMD Resmed IncSold$228K
Aug 5, 2026RMD Resmed IncSold$1.8M
Jun 5, 2026ARCT Arcturus Therapeutics Holdings IncBought (not open market)—
Apr 1, 2026RMD Resmed IncSold$450K
Mar 4, 2026RMD Resmed IncSold$520K
Feb 4, 2026RMD Resmed IncSold$503K
Jan 7, 2026RMD Resmed IncSold$498K
Dec 3, 2025RMD Resmed IncSold$503K
Nov 24, 2025RMD Resmed IncBought (not open market)$333K
Nov 20, 2025RMD Resmed IncBought (not open market)—
Nov 14, 2025RMD Resmed IncSold (not open market)$1.8M
Nov 14, 2025RMD Resmed IncBought (not open market)—
Nov 12, 2025RMD Resmed IncSold$504K
Nov 11, 2025RMD Resmed IncSold (not open market)$40.8K

Companies traded

  • RMD Resmed Inc: 98 sales, last Sep 2, 2026
  • ARCT Arcturus Therapeutics Holdings Inc: 2 buys, last Jun 5, 2026
  • EOLS Evolus, Inc: 1 buy, last Jan 27, 2023
  • NUVA Nuvasive Inc: 1 buy, 2 sales, last May 3, 2018

Get free alerts when Peter C Farrell files a new trade →